Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Biogen’s stock increased by 1% on Thursday following a positive opinion from Europe’s pharmaceutical regulator regarding their Alzheimer’s disease drug ...
Biogen’s stock increased by 1% on Thursday following a positive opinion from Europe’s pharmaceutical regulator regarding their Alzheimer’s disease drug ...
Shares of Cassava Sciences Inc. dropped over 10% in after-hours trading following a settlement with U.S. securities regulators over misleading ...
out of the summary. A recent study has found that the diagnoses of Alzheimer’s and other dementia can vary by ...
New research suggests that sleeping less than six hours per night may increase the risk of developing Alzheimer's disease. The ...
The FDA has approved a second drug for the treatment of Alzheimer's disease that can modestly slow the progression of ...
The Young Blood Institute's innovative early detection model is revolutionizing Alzheimer's care by identifying individuals at risk before symptoms even ...
A recent study revealed that the financial burden of Alzheimer's disease begins long before the official diagnosis. Researchers found that ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.